These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 9758307)
1. Pharmacotherapy of primary obsessive-compulsive disorder: review of the literature. Ellingrod VL Pharmacotherapy; 1998; 18(5):936-60. PubMed ID: 9758307 [TBL] [Abstract][Full Text] [Related]
2. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible? Todorov C; Freeston MH; Borgeat F Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic management of obsessive-compulsive disorder. Jackson CW; Morton WA; Lydiard RB South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850 [TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
5. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308 [TBL] [Abstract][Full Text] [Related]
6. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
7. Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report. Paholpak S J Med Assoc Thai; 2002 Oct; 85(10):1135-8. PubMed ID: 12501907 [TBL] [Abstract][Full Text] [Related]